Logo
  • Email: leon@elitelntellectsnetwork.com
  • Address: Room F, 26th Floor, Phase 2, Yijing Plaza, 10 Cheung Yu Street, Sham Shui Po District, Kowloon, Hong Kong

Covid-19: Three purchasing behaviour trends at molecular labs (Asia-Pacific)

NEWS ALL

CONTACT US
SEND MAIL

SEND MAIL

Mail: leon@insightestuary.com

Covid-19 has not only impacted test volumes but also spurred changes in test practices and purchasing behaviour in Asia-Pacific’s (APAC’s) molecular diagnostics (MDx) labs.

EIU Healthcare surveyed some 300 MDx labs across APAC to understand how they are responding to Covid-19 and identify what they need to manage the demands of Covid-19 testing more successfully.

Download the infographic and find out:

  • Percentage of labs surveyed that have already expanded their testing capacity through instrument purchases

  • Percentage of labs surveyed that plan to further expand testing capacity through instrument purchases

  • What is the demand for respiratory panel testing?

  • How important is a local/regional supply of IVD tests and instruments for labs?

  • How IVD companies can support labs in navigating Covid-19 testing demands?

Download infographic

Simply fill in the form below to access the infographic

From time to time, we would like to contact you with relevant updates, newly released content, events or special offers from The Economist Group.

By submitting this form, you are agreeing to receive information from Economist Intelligence. At any point you can update your preferences or unsubscribe from communications by clicking the link(s) at the bottom of our emails. Further information about our terms of use and privacy policy can be found here.

Sign up for our EIU Healthcare newsletter and never miss an insight from our specialists and analysts.

We will email you when new articles are published on this topic.

Sign up for the newsletter


Go To Top